Dexmedetomedine

PreclinicalSmall molecule

AAlRefaey Kandeel

Dexmedetomedine is one of 65 small molecule programs targeting Liver Transplant. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Liver TransplantActive, not recruiting

Inguinal HerniaActive, not recruiting

HepatectomyCompleted

Liver TransplantPreclinical

Active, not recruiting

Inguinal HerniaPreclinical

Active, not recruiting

HepatectomyPreclinical

Completed

Competition

Competitive Landscape

95 competitors in Liver Transplant

#DrugCompanyPhaseTrials

Giapreza

LLa Jolla Pharmaceutical Company

Phase 3

1 2

Prothrombin Complex Concentrate

CSL Behring

Phase 3

1 3

Darbepoetin

Bayer

Phase 3

1 4

Tacrolimus Pill

EEdward Geissler

Phase 3

1 5

Lenvima

Eisai

Preclinical

2 6

Octreotide

Johnson & Johnson

Preclinical

2 7

Beyfortus

BeiGene

Preclinical

1 8

Prostigmin

Merck & Co.

Preclinical

1 9

Myfortic

Novartis

Preclinical

1 10

Cyklokapron

JJ Molner

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Hepatectomy2 trials

Transversus Abdominus Plane Block in Living Donor Hepatectomy

Completed·AAlRefaey Kandeel·N/A·NCT02708459·90 enrolled

Dexmedetomedine Infusion Versus Fentanyl Infusion for Donor Anlgesia During Living Donor Hepatectomy

Completed·MMansoura University·N/A·NCT02531529·70 enrolled

Liver Transplant1 trial

Propofol Versus Dexmedetomidine for Prevention of Sevoflurane Agitation in Recipients of Living Donor Liver Transplantation

Unknown status·AAlRefaey Kandeel·N/A·NCT02544906·120 enrolled

Inguinal hernia1 trial

Dexmedetomidine vs Ketofol on Delirium in Children Undergoing Congenital Inguinal Hernia Repair

Unknown status·TTanta University·N/A·NCT05786833·60 enrolled

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for Dexmedetomedine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Dexmedetomedine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Dexmedetomedine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — AlRefaey Kandeel company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: AAlRefaey Kandeel

Dexmedetomedine

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Hepatectomy2 trials

Liver Transplant1 trial

Inguinal hernia1 trial

References

Drug Info

Quick Facts

Related News